UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Loss-of-Function Variants in DRD1 in Infantile Parkinsonism-Dystonia

Reid, Kimberley M; Steel, Dora; Nair, Sanjana; Bhate, Sanjay; Biassoni, Lorenzo; Sudhakar, Sniya; Heys, Michelle; ... Kurian, Manju A; + view all (2023) Loss-of-Function Variants in DRD1 in Infantile Parkinsonism-Dystonia. Cells , 12 (7) , Article 1046. 10.3390/cells12071046. Green open access

[thumbnail of cells-12-01046-v2.pdf]
Preview
Text
cells-12-01046-v2.pdf - Published Version

Download (2MB) | Preview

Abstract

The human dopaminergic system is vital for a broad range of neurological processes, including the control of voluntary movement. Here we report a proband presenting with clinical features of dopamine deficiency: severe infantile parkinsonism-dystonia, characterised by frequent oculogyric crises, dysautonomia and global neurodevelopmental impairment. CSF neurotransmitter analysis was unexpectedly normal. Triome whole-genome sequencing revealed a homozygous variant (c.110C>A, (p.T37K)) in DRD1, encoding the most abundant dopamine receptor (D1) in the central nervous system, most highly expressed in the striatum. This variant was absent from gnomAD, with a CADD score of 27.5. Using an in vitro heterologous expression system, we determined that DRD1-T37K results in loss of protein function. Structure-function modelling studies predicted reduced substrate binding, which was confirmed in vitro. Exposure of mutant protein to the selective D1 agonist Chloro APB resulted in significantly reduced cyclic AMP levels. Numerous D1 agonists failed to rescue the cellular defect, reflected clinically in the patient, who had no benefit from dopaminergic therapy. Our study identifies DRD1 as a new disease-associated gene, suggesting a crucial role for the D1 receptor in motor control.

Type: Article
Title: Loss-of-Function Variants in DRD1 in Infantile Parkinsonism-Dystonia
Location: Switzerland
Open access status: An open access version is available from UCL Discovery
DOI: 10.3390/cells12071046
Publisher version: https://doi.org/10.3390/cells12071046
Language: English
Additional information: © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Keywords: DRD1, dopamine, dystonia, parkinsonism, Humans, Receptors, Dopamine D1, Dystonia, Dystonic Disorders, Parkinson Disease
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Population, Policy and Practice Dept
URI: https://discovery.ucl.ac.uk/id/eprint/10168332
Downloads since deposit
16Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item